These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1703436)

  • 21. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors.
    Rezaie AR
    Biochemistry; 1999 Nov; 38(44):14592-9. PubMed ID: 10545182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparin.
    van Meijer M; Smilde A; Tans G; Nesheim ME; Pannekoek H; Horrevoets AJ
    Blood; 1997 Sep; 90(5):1874-82. PubMed ID: 9292520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes.
    Andreasen PA; Sottrup-Jensen L; Kjøller L; Nykjaer A; Moestrup SK; Petersen CM; Gliemann J
    FEBS Lett; 1994 Feb; 338(3):239-45. PubMed ID: 8307187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional effects of single amino acid substitutions in the region of Phe113 to Asp138 in the plasminogen activator inhibitor 1 molecule.
    Sui GC; Wiman B
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):409-15. PubMed ID: 9531478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activator.
    van Meijer M; Stoop A; Smilde A; Preissner KT; van Zonneveld AJ; Pannekoek H
    Thromb Haemost; 1997 Mar; 77(3):516-21. PubMed ID: 9066004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R; Umemura K; Hashimmoto H; Urano T
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitronectin.
    Tomasini BR; Mosher DF
    Prog Hemost Thromb; 1991; 10():269-305. PubMed ID: 1706881
    [No Abstract]   [Full Text] [Related]  

  • 28. Secretion of plasminogen activator and its inhibitor by glomerular epithelial cells.
    Iwamoto T; Nakashima Y; Sueishi K
    Kidney Int; 1990 Jun; 37(6):1466-76. PubMed ID: 2113968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific glycosaminoglycans support the inhibition of thrombin by plasminogen activator inhibitor 1.
    Gebbink RK; Reynolds CH; Tollefsen DM; Mertens K; Pannekoek H
    Biochemistry; 1993 Feb; 32(6):1675-80. PubMed ID: 8431448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin cofactor II inhibits thrombin-stimulated release of tissue plasminogen activator from cultured human endothelial cells in the presence of dermatan sulfate.
    Kaji T; Ejiri N; Hayakawa Y; Hayashi T; Sakuragawa N
    Thromb Res; 1990 Jul; 59(2):269-77. PubMed ID: 2122537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor.
    Pratt CW; Church FC
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):479-90. PubMed ID: 8392392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin.
    Salonen EM; Vaheri A; Pöllänen J; Stephens R; Andreasen P; Mayer M; Danø K; Gailit J; Ruoslahti E
    J Biol Chem; 1989 Apr; 264(11):6339-43. PubMed ID: 2467912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular advances in plasminogen activator inhibitor 1 interaction with thrombin and tissue-type plasminogen activator.
    Stoop A; van Meijer M; Horrevoets AJ; Pannekoek H
    Trends Cardiovasc Med; 1997 Feb; 7(2):47-51. PubMed ID: 21235863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
    Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB
    Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells.
    Rosenfeld L; Kuo A; Hirsh J; Klugherz B; Gardell SJ; Cines DB; Barnathan ES
    Blood; 1992 Sep; 80(6):1486-95. PubMed ID: 1520875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C.
    Fay WP; Owen WG
    Biochemistry; 1989 Jul; 28(14):5773-8. PubMed ID: 2505842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin.
    Owensby DA; Morton PA; Wun TC; Schwartz AL
    J Biol Chem; 1991 Mar; 266(7):4334-40. PubMed ID: 1705551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator.
    Declerck PJ; De Mol M; Vaughan DE; Collen D
    J Biol Chem; 1992 Jun; 267(17):11693-6. PubMed ID: 1601844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.